The ACE2 binding affinity identified in the 2019-nCoV spike protein ectodomain is roughly 10–20-fold higher as compared to that of the SARS-CoV spike protein, thus justifying the higher required affinity of the COVID-19 spike protein to the human counterpart (ACE2) receptor (13). This evidence concerns the gene ACE2 and COVID-19.